Has Claudel Gratia, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,467 in general payments to Claudel Gratia, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Claudel Gratia, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Claudel Gratia, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Claudel Gratia, MD

Internal Medicine · Savannah, GANPI 1508001496

Payments from drug & device makers

$1,467in general payments, 2019–2025

Across 82 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$496
E.r. Squibb & Sons, L.L.C.$274
Johnson & Johnson$223
AbbVie$199
Merck$107
AstraZeneca$80
plus $88 from 3 others

What the payments were for

Food & beverage$1,467100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	26	$496
E.r. Squibb & Sons, L.L.C.	16	$274
Johnson & Johnson	16	$223
AbbVie(2 entities)	7	$199
Merck	7	$107
AstraZeneca(2 entities)	5	$80
Medtronic(2 entities)	2	$32
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$31
Shionogi Inc	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TEFLARO$105

How this compares

$1,467 in reported general payments places this provider in the 70th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$83,766

Medicare patients

353

Services billed

811

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	11	$7,082
Cefdinir	14	$147
Pantoprazole Sodium	15	$113
Atorvastatin Calcium	18	$101
ClopidogrelClopidogrel Bisulfate	15	$100
Metoprolol Succinate	11	$78
Doxycycline Hyclate	15	$77
Levofloxacin	16	$72
Amlodipine Besylate	21	$57
Carvedilol	12	$43
Ciprofloxacin Hcl	11	$42
Furosemide	19	$27
Prednisone	11	$13

Paid to pharmacies, not to this prescriber.

Other internal medicine in Savannah

Paul BradleySavannah$76.4M
Thomas MoriaritySavannah$4.6M
Nancy BackusSavannah$1.2M
Robert RemlerSavannah$255K
Jennifer WoehlerSavannah$207K
Brooke HalpernSavannah$185K
Kimball JohnsonAtlanta$51.1M
Bram WieskopfWoodstock$21.9M
Dwight BlakeUnion City$13.3M
Charlotte Grayson-MathisFayetteville$9.6M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →